SciELO - Scientific Electronic Library Online

vol.26 issue2Cross Infection in maxillofacial surgery author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Revista Española de Cirugía Oral y Maxilofacial

On-line version ISSN 2173-9161Print version ISSN 1130-0558


DELGADO SANCHEZ, M. et al. Efficacy of single drug therapy with piperacillin-tazobactam in infections of the maxillofacial area. Rev Esp Cirug Oral y Maxilofac [online]. 2004, vol.26, n.2, pp.97-106. ISSN 2173-9161.

Abstract: Objective: Maxillofacial infections are a frequent cause for consulting maxillofacial surgeons. Dental problems are the most frequent source of infections, these being typically polymicrobial. For these reasons, safety and efficacy of piperacillin/tazobactam in maxillofacial infections were evaluated in this study. Design: Multicenter and prospective study in which seventy-nine patients with maxillofacial infections were treated with piperacillin/tazobactam. Results: 97.5% of the evaluable patients were clinically cured or improved and the bacteriologic eradication rate was 96.2%. Five out of 79 (6.3%) had an adverse event (two dyspepsia, two dizziness and one phlebitis). No deaths were attributable to the study drug. Conclusions: Piperacillin/tazobactam is a good single drug treatment choice for maxillofacial infections.

Keywords : maxillofacial infections; piperacillin-tazobactam; clinical efficacy; safety.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License